Abstract: The present invention relates to a novel probe set for an isothermal one-pot reaction, and uses thereof and, particularly, provides a method for easily, accurately, and quickly diagnosing molecules, in particular, infection diseases, in the field, the method having a form applicable in the field on the basis of a nucleic acid sequence by using a one-pot reaction composition under an isothermal condition. If a molecular diagnostic platform according to the present invention is used, a target sequence can be quickly and accurately detected.

Abstract: A battery cell has asymmetrically formed electrode leads, and a battery module including the same. The spatial efficiency and the mechanical strength of the battery module are improved.

Abstract: An electrolyte solution for a lithium secondary battery and a lithium secondary battery including the same are disclosed herein. In some embodiments, an electrolyte solution includes a lithium salt, an additive including a compound represented by Formula 1, and an organic solvent. In some embodiments, the lithium secondary battery includes a positive electrode, a negative electrode which includes a negative electrode active material containing SiOx (0<x?2), a separator, and the electrolyte solution.

Abstract: A battery cell has asymmetrically formed electrode leads, and a battery module includes the same. The spatial efficiency and the mechanical strength of the battery module are improved.

Abstract: A method of performing autonomous driving based on platooning by a moving object includes setting a moving path, determining whether platooning is allowed, transmitting moving path information to a first intelligent transportation system infrastructure when the moving object of a plurality of moving objects approaches a preset range of the first intelligent transportation system infrastructure, receiving platooning information from the first intelligent transportation system infrastructure, and performing platooning based on the platooning information, wherein the first intelligent transportation system infrastructure groups ones of the moving objects capable of platooning from among the plurality of moving objects based on the moving path information received from each of the plurality of moving objects.

Abstract: A non-aqueous electrolyte solution for a lithium secondary battery and a lithium secondary battery including the same are disclosed herein. In some embodiments, non-aqueous electrolyte solution includes a lithium salt, an organic solvent, and a compound represented by Formula 1 as a first additive. A lithium secondary battery including the non-aqueous electrolyte has improved flame retardancy.

Abstract: A non-aqueous electrolyte solution and a lithium secondary battery including the same are disclosed herein. In some embodiments, a non-aqueous electrolyte solution for a lithium secondary battery includes a lithium salt, an organic solvent, a compound represented by Formula 1 as a first additive, and lithium difluorophosphate as a second additive, wherein a weight ratio of the first additive to the second additive is in a range of 1:2 to 1:10.

Abstract: The present invention relates to a method for generating a single-stranded region for detecting genetic mutation and a method for detecting genetic mutation using same. A detection method according to the present invention can detect sequence-specific nucleic acids and detect mutations at the single nucleotide polymorphism (SNP) discrimination level, thereby allowing for the accurate and sensitive discrimination of mutations in a short time. Thus, the present invention provides an effective mutation detection method that can respond not only to current SARS-CoV-2 variants but also generally to specific diseases or related mutations in the future.

Abstract: The present invention relates to squid-derived peptides and uses thereof and, more specifically, to uses of squid-derived peptides squidtocin and pro-sepiatocin for prevention or treatment of V1B receptor-related diseases. It has been confirmed that the squidtocin and pro-sepiatocin according to the present invention have an effect of inducing activation of a V1B receptor which is a type of vasopressin receptor. The V1B receptor which is a type of vasopressin receptor is present in the anterior pituitary and in the hippocampal CA2 region, and it is known that the V1B receptor increases intracellular calcium concentration and is involved in response to stress and sociality. Accordingly, the squidtocin and the pro-sepiatocin according to the present invention can be used in various ways in the field of prevention, amelioration, or treatment of V1B receptor-related diseases.

Abstract: A battery module includes a cell stack in which a plurality of battery cells are stacked; a pair of bus bar frames configured to cover one side and another side, respectively, of the cell stack in a longitudinal direction; a housing configured to accommodate a combined body of the cell stack and the pair of bus bar frames so that the pair of bus bar frames is exposed to an outside of the housing; and an insulation pad interposed between a side surface of the cell stack and an inner surface of the housing and between a side surface of one of the pair of bus bar frames and the inner surface of the housing.

Abstract: The present invention relates to a novel peptide that specifically binds to nucleolin and, more specifically, to a peptide represented by a specific amino acid sequence, a conjugate comprising the peptide and an anticancer drug, a fusion peptide comprising the peptide and a cell-penetrating peptide, a composition for diagnosing cancer comprising the peptide, and a composition for preventing or treating cancer comprising the peptide or the conjugate. In the present invention, it has been confirmed that a peptide ligand AGM peptide and mutants thereof, as screened using an MAP synthesis method and an OBOC combination method, specifically bind to cancer cells, and a conjugate thereof with an anticancer drug inhibits cancer growth (in vitro and in vivo). Thus, the NCL-targeting AGM peptide can be effectively used for diagnosis and targeted drug delivery in cancer therapy.

Abstract: Disclosed is a video processing system including multiple unmanned aerial vehicles (UAVs) configured to capture a video of a fire site, wherein each UAV has a control unit including an input layer and a first hidden layer (hidden layer 1) and a central server connected to the multiple UAVs by wireless communication, wherein the central server includes multiple hidden layers and an output layer. The video processing system performs a learning process to determine whether a fire has occurred using a feature map in which an original video is difficult to recognize and personal information is protected. Thus, it is possible to fundamentally prevent the exposure and infringement of personal information.

Abstract: A method of manufacturing a dielectric slurry, includes supplying a dielectric slurry including dielectric particles and a solvent to a slurry supply module, dispersing the dielectric slurry by inserting the dielectric slurry into a particle dispersing module, classifying the dielectric particles according to particle size by inserting the dispersed dielectric slurry into a classifying module, recovering at least a portion of the dielectric particles to the slurry supply module, and redispersing the dielectric slurry including the dielectric particles recovered to the slurry supply module to the particle dispersing module.

Abstract: Disclosed is a video processing system including multiple unmanned aerial vehicles (UAVs) configured to capture a video of a fire site, wherein each UAV has a control unit including an input layer and a first hidden layer (hidden layer 1) and a central server connected to the multiple UAVs by wireless communication, wherein the central server includes multiple hidden layers and an output layer. The video processing system performs a learning process to determine whether a fire has occurred using a feature map in which an original video is difficult to recognize and personal information is protected. Thus, it is possible to fundamentally prevent the exposure and infringement of personal information.

Abstract: A composition for promoting longitudinal bone growth, according to the present invention, promotes the proliferation of the chondrocytes and the differentiation of the osteoblasts and has effects of simultaneously increasing longitudinal bone length and thickness (bone density), and thus has an advantage of being widely prescribable to various age groups, thereby being usable as a pharmaceutical composition for promoting the growth of longitudinal bone length and thickness. An indirubin derivative according to the present invention has prevention or treatment effects through oral administration. In addition, unlike conventional therapeutic agents, the pharmaceutical composition for preventing or treating bone diseases of the present invention is a stable compound, which is known to be substantially noncytotoxic to the human body, and is a material of which adverse effects have not been identified and has excellent treatment effects for bone diseases and osteogenesis imperfecta.

Abstract: A method for controlling charging of a high voltage power grid structure of a vehicle is provided. The method includes measuring battery voltage of a vehicle and transmitting the measured voltage to a first charger. Output voltage of the first charger is matched with the transmitted voltage and provided to a charging controller via communication between the charging controller and the first charging port to which the first charger is coupled. The vehicle is then charged by connecting a high-voltage relay to be connected to a first charging port to which the first charger is coupled. The process is repeated while the vehicle is being charged between the charging controller and a second charger by connecting to a second charging port to which a second charger is coupled.

Abstract: The present invention relates to an antibody carrier based on a gold nanoparticle (AuNP)-aptamer conjugate and a method of preparing the same. The antibody carrier according to the present invention is prepared by binding of an immunoglobulin G (IgG) Fc domain-specific aptamer or a fluorescein isothiocyanate (FITC)-specific aptamer to AuNP, and may effectively deliver an antibody into the cell nucleus, the cytoplasm and mitochondria by specific binding of the antibody to be delivered to the aptamer. In addition, since the AuNP having very low cytotoxicity is used, the antibody carrier is not only harmless to the human body, but may also detect a location in cells easily by reflecting light at various wavelengths, and therefore, it is expected to be effectively used in diagnosis or treatment of a disease.

Abstract: Provided are a controller configured to perform secure deletion, a key-value storage device including the controller, and a method of operating the key-value storage device. The key-value storage device includes a non-volatile memory including a plurality of blocks, and a controller configured to control a memory operation on the non-volatile memory, receive a write command including a first key and a first value corresponding to the first key from a host, write data of a file corresponding to the first value to at least one block of the plurality of blocks of the non-volatile memory in response to the write command, receive a secure deletion command for the first value from the host, and erase the at least one block to which the first value is written, in response to the secure deletion command.

Abstract: A bacterial adsorption dressing in contact with a wound and a method of manufacturing the bacterial adsorption dressing are provided. A bacterial adsorption dressing with a nonphotocatalyst includes a fabric layer including a polyester fiber as a supporter, and a nonphotocatalyst coating layer formed on the fabric layer and including titanium dioxide phosphate.

Abstract: A method for controlling charging of a high voltage power grid structure of a vehicle is provided. The method includes measuring battery voltage of a vehicle and transmitting the measured voltage to a first charger. Output voltage of the first charger is matched with the transmitted voltage and provided to a charging controller via communication between the charging controller and the first charging port to which the first charger is coupled. The vehicle is then charged by connecting a high-voltage relay to be connected to a first charging port to which the first charger is coupled. The process is repeated while the vehicle is being charged between the charging controller and a second charger by connecting to a second charging port to which a second charger is coupled.